Zhou et al. [9], was among the first to assessed temporal changes of laboratory circulating markers in hospitalized patients with COVID-19 from illness onset and demonstrated that patients who did not survive had significantly higher and progressively increasing levels of IL-6, serum ferritin, and D-dimer beginning on days 7 to 10 compared with those who survived. The gene discussed is IL6; the disease is COVID-19.